London Company of Virginia’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$392M Sell
1,604,354
-113,839
-7% -$26.5M 2.42% 6
2025
Q4
$356M Sell
1,718,193
-49,182
-3% -$9.73M 2.05% 11
2025
Q3
$328M Sell
1,767,375
-42,828
-2% -$7.34M 1.81% 18
2025
Q2
$277M Sell
1,810,203
-47,835
-3% -$7.35M 1.56% 25
2025
Q1
$308M Buy
1,858,038
+14,949
+0.8% +$2.34M 1.76% 18
2024
Q4
$267M Sell
1,843,089
-255,420
-12% -$39.6M 1.46% 24
2024
Q3
$340M Sell
2,098,509
-117,576
-5% -$18.7M 1.79% 15
2024
Q2
$324M Sell
2,216,085
-119,555
-5% -$17.8M 1.82% 14
2024
Q1
$369M Sell
2,335,640
-67,642
-3% -$10.8M 1.95% 14
2023
Q4
$377M Sell
2,403,282
-170,673
-7% -$26.2M 2.12% 10
2023
Q3
$401M Sell
2,573,955
-69,820
-3% -$11.5M 2.41% 5
2023
Q2
$438M Sell
2,643,775
-58,569
-2% -$9.45M 2.48% 6
2023
Q1
$419M Sell
2,702,344
-74,740
-3% -$12.1M 2.42% 7
2022
Q4
$491M Buy
2,777,084
+4,821
+0.2% +$832K 2.89% 3
2022
Q3
$453M Buy
2,772,263
+70,776
+3% +$12M 2.87% 4
2022
Q2
$480M Sell
2,701,487
-84,905
-3% -$15.1M 2.93% 2
2022
Q1
$494M Buy
2,786,392
+64,278
+2% +$10.9M 2.61% 5
2021
Q4
$466M Sell
2,722,114
-75,904
-3% -$12.4M 2.35% 7
2021
Q3
$452M Buy
2,798,018
+54,598
+2% +$9.31M 2.48% 8
2021
Q2
$452M Buy
2,743,420
+28,820
+1% +$4.77M 2.41% 8
2021
Q1
$446M Buy
2,714,600
+72,696
+3% +$11.8M 2.56% 7
2020
Q4
$416M Buy
2,641,904
+322,720
+14% +$47.6M 2.6% 6
2020
Q3
$345M Buy
2,319,184
+698,409
+43% +$103M 2.46% 7
2020
Q2
$228M Buy
1,620,775
+23,106
+1% +$3.37M 1.77% 21
2020
Q1
$210M Buy
1,597,669
+3,651
+0.2% +$518K 2% 14
2019
Q4
$233M Sell
1,594,018
-15,060
-0.9% -$2.04M 1.79% 18
2019
Q3
$208M Sell
1,609,078
-11,770
-0.7% -$1.55M 1.71% 24
2019
Q2
$226M Buy
1,620,848
+5,164
+0.3% +$715K 1.94% 13
2019
Q1
$226M Buy
1,615,684
+22,352
+1% +$2.99M 1.93% 15
2018
Q4
$206M Sell
1,593,332
-156,025
-9% -$21.8M 1.96% 13
2018
Q3
$242M Buy
1,749,357
+1,744,867
+38,861% +$232M 1.88% 14
2018
Q2
$545K Hold
4,490
﹤0.01% 117
2018
Q1
$575K Sell
4,490
-935
-17% -$126K ﹤0.01% 114
2017
Q4
$763K Sell
5,425
-109
-2% -$15.2K 0.01% 114
2017
Q3
$719K Sell
5,534
-150
-3% -$19.9K 0.01% 110
2017
Q2
$752K Sell
5,684
-2,382
-30% -$304K 0.01% 110
2017
Q1
$1M Sell
8,066
-58
-0.7% -$6.93K 0.01% 108
2016
Q4
$936K Sell
8,124
-175
-2% -$20.2K 0.01% 106
2016
Q3
$980K Sell
8,299
-2,791
-25% -$339K 0.01% 101
2016
Q2
$1.34M Buy
11,090
+598
+6% +$68K 0.01% 97
2016
Q1
$1.14M Sell
10,492
-3,102
-23% -$321K 0.01% 98
2015
Q4
$1.4M Buy
13,594
+175
+1% +$17.6K 0.01% 105
2015
Q3
$1.25M Sell
13,419
-170
-1% -$16.4K 0.01% 108
2015
Q2
$1.32M Buy
13,589
+4,552
+50% +$456K 0.01% 105
2015
Q1
$909K Buy
9,037
+2,467
+38% +$251K 0.01% 105
2014
Q4
$687K Sell
6,570
-53
-0.8% -$5.58K 0.01% 100
2014
Q3
$706K Buy
6,623
+4,689
+242% +$486K 0.01% 98
2014
Q2
$202K Sell
1,934
-159,994
-99% -$16.2M ﹤0.01% 115
2014
Q1
$15.9M Buy
161,928
+15,885
+11% +$1.47M 0.18% 80
2013
Q4
$13.4M Buy
146,043
+9,999
+7% +$922K 0.15% 80
2013
Q3
$11.8M Buy
136,044
+12,699
+10% +$1.14M 0.16% 80
2013
Q2
$10.6M Buy
+123,345
New +$10.5M 0.15% 76

Other funds holding JNJ

London Company of Virginia's JNJ Position: Q1 2026 in Review

London Company of Virginia reduced its Johnson & Johnson (JNJ) stake by 6.6% in Q1 2026, selling an estimated $26.5M and leaving 1,604,354 shares worth $392M. The position accounts for 2.42% of the portfolio, ranked #6.

London Company of Virginia first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $494M in Q1 2022. 4,631 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • London Company of Virginia held 1,604,354 shares of Johnson & Johnson worth $392M as of Q1 2026.
  • London Company of Virginia sold 113,839 Johnson & Johnson shares in Q1 2026, an estimated $26.5M.
  • Johnson & Johnson made up 2.42% of London Company of Virginia's portfolio in Q1 2026, its #6 holding.
  • London Company of Virginia first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • London Company of Virginia's Johnson & Johnson position peaked at $494M in Q1 2022.
  • 4,631 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on London Company of Virginia's 13F filing for Q1 2026, filed 15 May 2026.